HPV Vaccination Study in Postpartum Women
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Pembrolizumab in MarginalzoneLymphoma A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY
- Status
- TERMINATED
- Phase
- PHASE2
Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)
- Status
- TERMINATED
- Phase
- PHASE2
Microbiota and Bone Fragility:Study of the Relation Between Gut Microbiota and Bone Microarchitecture
- Status
- COMPLETED
- Phase
- NA
Applying Best Clinical Practices to Patients at High Risk of Respiratory Complications
- Status
- COMPLETED
- Phase
- PHASE4
The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Neo-adjuvant Pembrolizumab in dMMR/ POLE-EDM Uterine Cancer Patients: a Feasibility Study
- Status
- COMPLETED
- Phase
- PHASE1
CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA
- Status
- UNKNOWN
- Phase
- N/A
A Study of Pembrolizumab Added to the Standard First-Line Therapy of Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) for NDMM NTE
- Status
- WITHDRAWN
- Phase
- PHASE2
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pembrolizumab + Paclitaxel in HR+/HER2- Non-luminal (by PAM50) Advanced Breast Cancer After CDK4/6 Inhibitor Progression
- Status
- TERMINATED
- Phase
- PHASE2
Low Pressure Pneumoperitoneum and Deep Neuromuscular Block vs. Standard During RARP to Improve Quality of Recovery; a Randomized Controlled Study.
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection
- Status
- WITHDRAWN
- Phase
- PHASE3
Elimination of HCV Through Linkage and In Prison Treatment of Incarcerated Populations (ECLIPSE)
- Status
- WITHDRAWN
- Phase
- PHASE4
Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)
- Status
- COMPLETED
- Phase
- PHASE3